Electrical Impedance Myography Detects Disease Progression over 12 to 24 Months in Facioscapulohumeral Muscular Dystrophy
EIM phase outcomes are reliable, valid, and sensitive to change over 12 to 24 months, supporting their potential utility as biomarkers in FSHD clinical trials. ANN NEUROL 2026.
Authors
- Leann Lewis
- Karlien Mul (ORCID: https://orcid.org/0000-0001-8487-9478)
- W. B. Martens
- Michaela Walker (ORCID: https://orcid.org/0000-0003-1197-1657)
- Perry Shieh
- D. Leung
- Rabi Tawil
- Leo H Wang
- Russell J. Butterfield
- Jeffrey M. Statland
- Michael P. McDermott
- ReSolve Investigators of the FSHD‐CTRN
- Kate Eichinger
- Nicholas E. Johnson
Institutions
- Kennedy Krieger Institute (US)
- Johns Hopkins University (US)
- Radboud University Nijmegen (NL)
- University of California, Los Angeles (US)
- Virginia Commonwealth University (US)
- University of Washington (US)
- University of Utah (US)
- Radboud University Medical Center (NL)
- University of Rochester Medical Center (US)
- University of Kansas Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- Annals of Neurology
- Published
- 2026-02-22
- DOI
- https://doi.org/10.1002/ana.78182
- Primary Topic
- Muscle Physiology and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00